Business Wire

Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to ...